Is There an Association Between Acromegaly and Thyroid Carcinoma? A Critical Review of the Literature

REFERENCES

• Baris D, Gridley G, Ron E, Weiderpass E, Mellemkjaer L, Ekbom A, Olsen JH, Baron JA, Fraumeni JF, Jr. Acromegaly and cancer risk: a cohort study in Sweden and Denmark. Cancer Causes Control 2002; 13: 395–400, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Barzilay J, Heatly GJ, Cushing GW. Benign and malignant tumors in patients with acromegaly. Arch Intern Med 1991; 151: 1629–1632, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Orme SM, McNally RJ, Cartwright RA, Belchetz PE. Mortality and cancer incidence in acromegaly: a retrospective cohort study. United Kingdom Acromegaly Study Group. J Clin Endocrinol Metab 1998; 83: 2730–2734, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Cheung NW, Boyages SC. Increased incidence of neoplasia in females with acromegaly. Clin Endocrinol (Oxf). 1997; 47: 323–327, [CROSSREF]
   PubMedGoogle Scholar
• Popovic V, Damjanovic S, Micic D, Nesovic M, Djurovic M, Petakov M, Obradovic S, Zoric S, Simic M, Penezic Z, Marinkovic J. Increased incidence of neoplasia in patients with pituitary adenomas. The Pituitary Study Group. Clin Endocrinol (Oxf). 1998; 49: 441–445, [CROSSREF]
   PubMedGoogle Scholar
• Ron E, Gridley G, Hrubec Z, Page W, Arora S, Fraumeni JF, Jr. Acromegaly and gastrointestinal cancer. Cancer 1991; 68: 1673–1677, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Nabarro JD. Acromegaly. Clin Endocrinol (Oxf). 1987; 26: 481–512
   PubMed Web of Science ®Google Scholar
• Gasperi M, Martino E, Manetti L, Arosio M, Porretti S, Faglia G, Mariotti S, Colao AM, Lombardi G, Baldelli R, Camanni F, Liuzzi A. Acromegaly Study Group of the Italian Society of Endocrinology. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study. J Endocrinol Invest 2002; 25: 240–245, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Cheung NW, Boyages SC. The thyroid gland in acromegaly; an ultrasonographic study. Clin Endocrinol (Oxf). 1997; 46: 545–549, [CROSSREF]
   PubMedGoogle Scholar
• Wuster C, Steger G, Schmelzle A, Gottswinter J, Minne HW, Ziegler R. Increased incidence of euthyroid and hyperthyroid goiters independently of thyrotropin in patients with acromegaly. Horm Metab Res 1991; 23: 131–134, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Junik R, Sawicka J, Kozak W, Gembicki M. Thyroid volume and function in patients with acromegaly living in iodine deficient areas. J Endocrinol Invest 1997; 20: 134–137, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Swearingen B, Barker FG, II, Katznelson L, Biller BM, Grinspoon S, Klibanski A, Moayeri N, Black PM, Zervas NT. Long-term mortality after transsphenoidal surgery and adjunctive therapy for acromegaly. J Clin Endocrinol Metab 1998; 83: 3419–3426, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB. Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and long-term results. J Clin Endocrinol Metab 1998; 83: 3411–3418, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Jenkins PJ, Besser M. Acromegaly and cancer: a problem. J Clin Endocrinol Metab 2001; 86: 2935–2941, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Melmed S. Acromegaly and cancer: not a problem?. J Clin Endocrinol Metab 2001; 86: 2929–2934, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Melmed S, Casanueva FF, Cavagnini F, Chanson P, Frohman L, Grossman A, Ho K, Kleinberg D, Lamberts S, Laws E, Lombardi G, Vance ML, Werder KV, Wass J, Giustina A. For the Acromegaly Treatment Consensus Workshop Participants. Guidelines for acromegaly management. J Clin Endocrinol Metab 2002; 87: 4054–4058, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Oppenheim Y, Yeh HC, Brandwein M, Tomer Y. Thyroid carcinoma in a patient with acromegaly. Thyroid 2001; 11: 1197–1198, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Franceschi S, Preston-Martin S, Dal Maso L, Negri E, La Vecchia C, Mack WJ, McTiernan A, Kolonel L, Mark SD, Mabuchi K, Jin F, Wingren G, Galanti R, Hallquist A, Glattre E, Lund E, Levi F, Linos D, Ron E. A pooled analysis of case-control studies of thyroid cancer. IV. Benign thyroid diseases. Cancer Causes Control 1999; 10: 583–595, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• From G, Mellemgaard A, Knudsen N, Jorgensen T, Perrild H. Review of thyroid cancer cases among patients with previous benign thyroid disorders. Thyroid 2000; 10: 697–700, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Miyakawa M, Saji M, Tsushima T, Wakai K, Shizume K. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels. J Clin Endocrinol Metab 1988; 67: 973–978, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Kasagi K, Shimatsu A, Miyamoto S, Misaki T, Sakahara H, Konishi J. Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland. Thyroid 1999; 9: 791–796, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Studer H, Peter HJ, Gerber H. Natural heterogeneity of thyroid cells: the basis for understanding thyroid function and nodular goiter growth. Endocrine Reviews 1989; 10: 125–135, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Minuto F, Barreca A, Del Monte P, Cariola G, Torre GC, Giordano G. Immunoreactive insulin-like growth factor I (IGF-I) and IGF-I-binding protein content in human thyroid tissue. J Clin Endocrinol Metab 1989; 68: 621–626, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Wolk A. The growth hormone and insulin-like growth factor I axis, and cancer. Lancet 2004; 363: 1336–1337, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Grinspoon S, Clemmons D, Swearingen B, Klibanski A. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly. J Clin Endocrinol Metab 1995; 80: 927–932, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• Ma J, Pollak MN, Giovannucci E, Chan JM, Tao Y, Hennekens CH, Stampfer MJ. Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3. J Natl Cancer Inst 1999; 91: 620–625, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Chan JM, Stampfer MJ, Giovannuci E, Gann PH, Ma J, Wilkinson P, Hennekens CH, Pollak M. Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study. Science 1998; 279: 563–566, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Renehan AG, Zwahlen M, Minder C, O’Dwyer ST, Shalet SM, Egger M. Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. Lancet 2004; 363: 1346–1353, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar
• Tramontano D, Cushing GW, Moses AC, Ingbar SH. Insulin-like growth factor-I stimulates the growth of rat thyroid cells in culture and synergizes the stimulation of DNA synthesis induced by TSH and Graves’-IgG. Endocrinology 1986; 119: 940–942, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Roger P, Taton M, van Sande J, Dumont J. Mitogenic effects of thyrotropin and adenosine 3’5’-monophosphate in differentiated normal human thyroid cells in vitro. J Clin Endocrinol Metab 1988; 66: 1158–1165, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Misaki T, Maciel RMB, Tramontano D, Moses AC, Lombardi A, Ingbar SH. Supranormal stimulation of deoxyribonucleic acid synthesis in FRTL5 cells by serum from patients with untreated acromegaly. J Clin Endocrinol Metab 1988; 66: 1227–1232, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Yashiro T, Ohba Y, Murakami H, Obara T, Tsushima T, Fujimoto Y, Shizume K, Ito K. Expression of insulin-like growth factor receptors in primary human thyroid neoplasms. Acta Endocrinol 1989; 121: 112–120, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Vella V, Sciacca L, Pandini G, Mineo R, Squatrito S, Vigneri R, Belfiore A. The IGF system in thyroid cancer: new concepts. Mol Pathol 2001; 54: 121–124, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMedGoogle Scholar
• van der Laan BF, Freeman JL, Asa SL. Expression of growth factors and growth factor receptors in normal and tumorous human thyroid tissues. Thyroid 1995; 5: 67–73, [PUBMED], [INFOTRIEVE]
   PubMedGoogle Scholar
• Vannelli GB, Barni T, Modigliani U, Paulin I, Serio M, Maggi M, Fiorelli G, Balboni GC. Insulin-like growth factor-I receptors in nonfunctioning thyroid nodules. J Clin Endocrinol Metab 1990; 71: 1175–1182, [PUBMED], [INFOTRIEVE]
   PubMed Web of Science ®Google Scholar
• Singer PA, Cooper DS, Daniels GH, Ladenson PW, Greenspan FS, Levy EG, Braverman LE, Clark OH, McDougall IR, Ain KV, Dorfman SG. Treatment guidelines for patients with thyroid nodules and well-differentiated thyroid cancer. American Thyroid Association. Arch Intern Med 1996; 156: 2165–2172, [PUBMED], [INFOTRIEVE], [CROSSREF]
   PubMed Web of Science ®Google Scholar